432 related articles for article (PubMed ID: 16044456)
21. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
Larson RA; Le Beau MM
Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
[TBL] [Abstract][Full Text] [Related]
22. Fludarabine-related myeloid leukemia.
Astrow AB
J Clin Oncol; 2003 Oct; 21(19):3709; author reply 3709-10. PubMed ID: 14512411
[No Abstract] [Full Text] [Related]
23. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
[No Abstract] [Full Text] [Related]
24. Myelodysplastic syndrome with complex karyotypic abnormality in a patient with Waldenström's macroglobulinemia after sequential treatment with chlorambucil and fludarabine.
Shin SJ; Chun SH; Kim KO; Kim MK; Lee KH; Hyun MS; Cho HS
Jpn J Clin Oncol; 2005 Oct; 35(10):622-5. PubMed ID: 16172172
[TBL] [Abstract][Full Text] [Related]
25. Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.
Flinn IW; Neuberg DS; Grever MR; Dewald GW; Bennett JM; Paietta EM; Hussein MA; Appelbaum FR; Larson RA; Moore DF; Tallman MS
J Clin Oncol; 2007 Mar; 25(7):793-8. PubMed ID: 17283364
[TBL] [Abstract][Full Text] [Related]
26. Pentostatin in chronic lymphocytic leukemia.
Sauter C; Lamanna N; Weiss MA
Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1217-22. PubMed ID: 18721115
[TBL] [Abstract][Full Text] [Related]
27. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
Fong D; Kaiser A; Spizzo G; Gastl G; Tzankov A
Br J Haematol; 2005 Apr; 129(2):199-205. PubMed ID: 15813847
[TBL] [Abstract][Full Text] [Related]
28. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
[No Abstract] [Full Text] [Related]
29. The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia.
Lemancewicz D; Dziecioł J; Kłoczko J; Piszcz J
Folia Morphol (Warsz); 2004 Nov; 63(4):485-9. PubMed ID: 15712148
[TBL] [Abstract][Full Text] [Related]
30. Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
Abdel-Raheem MM; Jamil MG; Potti A; Gross GG
Haematologica; 2000 Nov; 85(11):1224-5. PubMed ID: 11064479
[No Abstract] [Full Text] [Related]
31. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
Au WY; Chan LC; Liang R; Kwong YL
Am J Hematol; 2006 Jun; 81(6):471-3. PubMed ID: 16680740
[No Abstract] [Full Text] [Related]
32. [Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia].
Léonard S; Hulin C; Anxionnat R; Grignon Y; Taillandier L; Vespignani H
Rev Neurol (Paris); 2002 Nov; 158(11):1121-3. PubMed ID: 12451348
[TBL] [Abstract][Full Text] [Related]
33. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
Rioufol C; Coiffier B
Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
[No Abstract] [Full Text] [Related]
34. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
Hussain K; Mazza JJ; Clouse LH
Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
[TBL] [Abstract][Full Text] [Related]
35. Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy.
Molica S; Vacca A; Tucc L; Ribatti D
Haematologica; 2005 May; 90(5):698-700. PubMed ID: 15921392
[TBL] [Abstract][Full Text] [Related]
36. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
37. Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications.
Hussain FT; Nguyen EP; Raza S; Knudson R; Pardanani A; Hanson CA; Van Dyke D; Tefferi A
Am J Hematol; 2012 Jul; 87(7):684-6. PubMed ID: 22565657
[TBL] [Abstract][Full Text] [Related]
38. Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues.
Larsen CR; Hansen PB; Clausen NT
Am J Hematol; 2002 May; 70(1):48-50. PubMed ID: 11994981
[TBL] [Abstract][Full Text] [Related]
39. Secondary neoplasms in two patients treated with purine analogues.
Schlaifer D; Riga-Huguet F; Pris J; Brousset P; Delannoy A; Bosly A
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):341. PubMed ID: 7971258
[No Abstract] [Full Text] [Related]
40. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
